Osteoblast function and osteomalacia in metastatic prostate cancer
- PMID: 8375452
- DOI: 10.1159/000474311
Osteoblast function and osteomalacia in metastatic prostate cancer
Abstract
This study has examined the effect of prostate cancer on bone matrix formation and mineralisation by osteoblasts, with special reference to osteomalacia. Sixty-seven patients with prostatic bone metastases underwent transiliac bone biopsy after double tetracycline labelling. Histomorphometric analysis was then undertaken in areas distant from, local to and infiltrated by prostate cancer. In bone free of tumour (n = 45) and bone surrounding metastases (n = 7) both matrix formation and corrected mineral apposition rate were low. By comparison osteoid surface, osteoid volume and mineral apposition rate were markedly increased within metastases (tumor-free bone vs. metastatic bone, p < 0.0001), a finding consistent with a high bone turnover state. Although osteoblast function was disturbed both within metastases and in tumour-free areas, classical osteomalacia was not associated with prostate cancer.
Similar articles
-
Histomorphometric analysis of sclerotic bone metastases from prostatic carcinoma special reference to osteomalacia.Cancer. 1983 Mar 1;51(5):918-24. doi: 10.1002/1097-0142(19830301)51:5<918::aid-cncr2820510526>3.0.co;2-j. Cancer. 1983. PMID: 6681595
-
Distinction between focally accelerated bone formation and osteomalacia in carcinoma of prostate metastasised to bone.Br J Urol. 1993 Jul;72(1):98-103. doi: 10.1111/j.1464-410x.1993.tb06467.x. Br J Urol. 1993. PMID: 8149187
-
[Prostatic osteocondensing metastases and osteomalacia. Value of histomorphometric study. Preliminary results].Presse Med. 1985 Oct 19;14(35):1823-7. Presse Med. 1985. PMID: 2933667 French.
-
Oncogenic osteomalacia associated with metastatic prostate carcinoma: case report and review of the literature.J Am Geriatr Soc. 1993 Sep;41(9):983-5. doi: 10.1111/j.1532-5415.1993.tb06765.x. J Am Geriatr Soc. 1993. PMID: 8409185 Review. No abstract available.
-
The spectrum of pathology in osteomalacia.Appl Pathol. 1987;5(3):160-71. Appl Pathol. 1987. PMID: 3304354 Review.
Cited by
-
Optimal bone health management strategies in patients with prostate cancer.Indian J Urol. 2013 Apr;29(2):89-99. doi: 10.4103/0970-1591.114024. Indian J Urol. 2013. PMID: 23956508 Free PMC article.
-
Systematic Review of the Outcomes of Surgical Treatment of Prostate Metastases to the Spine.Global Spine J. 2017 Aug;7(5):460-468. doi: 10.1177/2192568217710911. Epub 2017 Jun 1. Global Spine J. 2017. PMID: 28811991 Free PMC article. Review.
-
Bone-targeted agents: preventing skeletal complications in prostate cancer.Urol Clin North Am. 2012 Nov;39(4):533-46. doi: 10.1016/j.ucl.2012.07.009. Epub 2012 Sep 4. Urol Clin North Am. 2012. PMID: 23084529 Free PMC article. Review.
-
New and emerging therapies for bone metastases in genitourinary cancers.Eur Urol. 2013 Feb;63(2):309-20. doi: 10.1016/j.eururo.2012.10.007. Epub 2012 Nov 23. Eur Urol. 2013. PMID: 23201471 Free PMC article. Review.
-
Bone health and prostate cancer.Prostate Cancer Prostatic Dis. 2010 Mar;13(1):20-7. doi: 10.1038/pcan.2009.50. Epub 2009 Nov 10. Prostate Cancer Prostatic Dis. 2010. PMID: 19901958 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Medical